Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 196 AL 210

Does lithium prevent Alzheimer's disease?

Forlenza OV, de Paula VJ, Machado-Vieira R, Diniz BS, Gattaz WF.

Drugs Aging. 2012 May 1;29(5):335-42. doi: 10.2165/11599180-000000000-00000.

Persons with Alzheimer's disease make phone calls independently using a computer-aided telephone system

Perilli V, Lancioni GE, Singh NN, O'Reilly MF, Sigafoos J, Cassano G, Cordiano N, Pinto K, Minervini MG, Oliva D.

Res Dev Disabil. 2012 Jul-Aug;33(4):1014-20. doi: 10.1016/j.ridd.2012.01.007. Epub 2012 Feb 21.

Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology

Perry EK, Johnson M, Ekonomou A, Perry RH, Ballard C, Attems J.

Neurobiol Dis. 2012 Aug;47(2):155-62. doi: 10.1016/j.nbd.2012.03.033. Epub 2012 Apr 5.

Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011)

Probst G, Xu YZ.

Expert Opin Ther Pat. 2012 May;22(5):511-40. doi: 10.1517/13543776.2012.681302. Epub 2012 Apr 19.

Meta-analysis of the association between the interleukin-1A -889C/T polymorphism and Alzheimer's disease

Hua Y, Zhao H, Kong Y, Lu X.

J Neurosci Res. 2012 Sep;90(9):1681-92. doi: 10.1002/jnr.23062. Epub 2012 Apr 19.

EphBs: an integral link between synaptic function and synaptopathies

Sheffler-Collins SI, Dalva MB.

Trends Neurosci. 2012 May;35(5):293-304. doi: 10.1016/j.tins.2012.03.003. Epub 2012 Apr 18.

Mitochondria, diabetes, and Alzheimer's disease

Milone M.

Diabetes. 2012 May;61(5):991-2. doi: 10.2337/db12-0209.

Possible usefulness of growth hormone/insulin-like growth factor-I axis in Alzheimer's disease treatment

Sáez JM.

Endocr Metab Immune Disord Drug Targets. 2012 Sep;12(3):274-86. doi: 10.2174/187153012802002857.

Opioid system and Alzheimer's disease

Cai Z, Ratka A.

Neuromolecular Med. 2012 Jun;14(2):91-111. doi: 10.1007/s12017-012-8180-3. Epub 2012 Apr 22.

Cell cycle activation and aneuploid neurons in Alzheimer's disease

Arendt T.

Mol Neurobiol. 2012 Aug;46(1):125-35. doi: 10.1007/s12035-012-8262-0. Epub 2012 Apr 13.

Cotinine: a potential new therapeutic agent against Alzheimer's disease

Echeverria V, Zeitlin R.

CNS Neurosci Ther. 2012 Jul;18(7):517-23. doi: 10.1111/j.1755-5949.2012.00317.x. Epub 2012 Apr 25.

Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease

Donovan LE, Higginbotham L, Dammer EB, Gearing M, Rees HD, Xia Q, Duong DM, Seyfried NT, Lah JJ, Levey AI.

Proteomics Clin Appl. 2012 Apr;6(3-4):201-11. doi: 10.1002/prca.201100068.

The role of inflammatory processes in Alzheimer's disease

Broussard GJ, Mytar J, Li RC, Klapstein GJ.

Inflammopharmacology. 2012 Jun;20(3):109-26. doi: 10.1007/s10787-012-0130-z. Epub 2012 Apr 26.

[Intended pharmacotherapeutical approaches of Alzheimer's disease therapy]

Korábecný J, Hrubá E, Soukup O, Zemek F, Musílek K, Nepovímová E, Spilovská K, Opletalová V, Kuca K.

Ceska Slov Farm. 2012 Feb;61(1-2):4-10.

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model

Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C.

Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias